Data / Form D filings / TrialScope, Inc.
TrialScope, Inc.: Form D filings
TrialScope, Inc., a pharmaceuticals company in Jersey City, NJ, filed 3 Form D notices with the SEC between 2014 and 2018. The latest, on September 17, 2018, reports $4 million sold of a $4.5 million offering to 5 investors.
Find out what TrialScope, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Harborside 5, 185 Hudson Street, Suite 2900, Jersey City, NJ, 07311
- Phone
- (212) 937-8271
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1610301
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 17, 2018 | New notice | $4,495,048 | $4,000,000 | $495,048 | 5 | Sep 5, 2018 | sec.gov |
| Apr 25, 2017 | New notice | $3,965,000 | $3,565,000 | $400,000 | 6 | Apr 12, 2017 | sec.gov |
| Jun 10, 2014 | New notice | $10,200,000 | $10,200,000 | $0 | 4 | May 30, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Kozloff | Executive Officer, Director | |
| Marc Lederman | Director | |
| Matthew C. Patras | Executive Officer | |
| James C. Walker | Director | |
| Larry C. Berran | Director | |
| Michael Kopelman | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Sep 17, 2018 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TrialScope, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.